SCHEMBL7701960

SCHEMBL7701960

COCC(=O)Nc1ccc(-c2oc(-c3ccccc3)nc2C(=O)N2CCN(c3ccccc3)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 4/20 0.52
L3MBTL1 Q9Y468 2/20 0.51
SMN1; SMN2 Q16637 4/20 0.48
MAPT P10636 6/20 0.47
LMNA P02545 3/20 0.47
ALDH1A1 P00352 2/20 0.47
MOK Q9UQ07 1/20 0.45
ADK P55263 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
PKM P14618 1/20 0.45
KMT2A Q03164 1/20 0.44
CETP P11597 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694001 0.90 MAPT (0.58) DGAT1L3MBTL1SMN1; SMN2MAPTLMNA
SCHEMBL7695331 0.88 USP2 (0.57) DGAT1L3MBTL1SMN1; SMN2MAPTLMNA
SCHEMBL7699467 0.88 ALDH1A1 (0.52) DGAT1L3MBTL1SMN1; SMN2MAPTALDH1A1
SCHEMBL7699897 0.88 L3MBTL1 (0.51) DGAT1L3MBTL1SMN1; SMN2MAPTLMNA
SCHEMBL7701794 0.87 SMN1; SMN2 (0.53) DGAT1L3MBTL1SMN1; SMN2MAPTALDH1A1
SCHEMBL7697962 0.87 L3MBTL1 (0.56) DGAT1L3MBTL1SMN1; SMN2MAPTALDH1A1
SCHEMBL7701952 0.86 MAPT (0.54) DGAT1L3MBTL1SMN1; SMN2MAPTLMNA
SCHEMBL7703324 0.84 L3MBTL1 (0.53) DGAT1L3MBTL1SMN1; SMN2MAPTALDH1A1
SCHEMBL7696391 0.84 MAPT (0.54) DGAT1L3MBTL1SMN1; SMN2MAPTALDH1A1
SCHEMBL7695770 0.83 MAPT (0.58) DGAT1L3MBTL1SMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002064558-A2 OXAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYTOKINE INHIBITORS SANKYO COMPANY, LIMITED (JP) 2002-08-22 WO disclosed